Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Agilent's ClearSeq AML, Emory's Pan-Ethnic Carrier Screen Test

Premium

Agilent Technologies has launched ClearSeq AML, a next-generation sequencing-based panel that targets 48 exons in 20 of the most commonly mutated genes in acute myeloid leukemia. Agilent researchers designed the panel in collaboration with Robert Ohgami and Daniel Arber at Stanford University. The panel provides 99.9 percent design coverage of targeted exons, according to the company and is based on its SureSelect and HaloPlex technology.


Emory Genetics Laboratory has launched its Pan-Ethnic Carrier Screen test, which is based on next-generation sequencing. The test screens for 725 mutations across 145 genes related to more than 140 genetic disorders, including all mutations recommended for screening by the American College of Medical Genetics and Genomics and the American Congress of Obstetricians and Gynecologists.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.